This compound is a secondary carboxamide formed from piperidine-4-carboxylic acid and a substituted thiazole-amine. It acts as an ATP-competitive inhibitor of CDK2, CDK7, and CDK9 kinases and has shown anti-cancer properties in research studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ketotifen fumarate
pharmaceutical raw material
Amoxicillin sodium
pharmaceutical raw material
Urapidil
pharmaceutical raw material
Alloferon
pharmaceutical raw material
N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide
OUSFTKFNBAZUKL-UHFFFAOYSA-N
CC(C)(C)C1=CN=C(O1)CSC2=CN=C(S2)NC(=O)C3CCNCC3
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.